Nasir M Idkaidek (Nasir Idkaidek)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Coronavirus Disease

Electronic Health Record

High Performance Liquid Chromatography

Top Venues

Journal of veterinary pharmacology and therapeutics

Biopharmaceutics & drug disposition

This page only lists publications with an associated author ORCID identifier.

Publications

Thaer Barri, Ruba Ramzi, Nasir M Idkaidek, Nabil N Al-Hashimi, Faisal Al-Akayleh, Ahmed S A Ali Agha
Hollow Fiber-in-Syringe Equilibrium Sampling Through Supported-Liquid Membrane for Evaluation of Drug-Plasma Binding. Bioanalysis (2024)
Feras Hawari, Yasmeen Dodin, Rabab Tayyem, Samer Najjar, Hanan Kakish, Mohammed Abu Fara, Abdullah Al Zou'bi, Nasir M Idkaidek
Safety, Tolerability, and Pharmacokinetics of Nebulized Hydroxychloroquine: A Pilot Study in Healthy Volunteers. Journal of aerosol medicine and pulmonary drug delivery (2023)
Ehab A Abu-Basha, Zuhiar B Ismail, Hind Abu Alhaijaa, Eyad Hamzeh, Nasir M Idkaidek
Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in sheep. Journal of veterinary pharmacology and therapeutics 44 (1) (2020)
Razan F Al-Qadri, Ehab A Abu-Basha, Mohammed M Ababneh, Zuhiar B Ismail, Nasir M Idkaidek
Pharmacokinetics of toltrazuril and its metabolites in pregnant and nonpregnant ewes and determination of their concentrations in milk, allantoic fluid, and newborn plasma. Journal of veterinary pharmacology and therapeutics 43 (4) (2020)
Nasir M Idkaidek, Feras Hawari, Yasmeen Dodin, Nour Obeidat
Development of a Physiologically-Based Pharmacokinetic (PBPK) Model of Nebulized Hydroxychloroquine for Pulmonary Delivery to COVID-19 Patients. Drug research 71 (5) (2020)
Nasir M Idkaidek, Salim Hamadi, Rabab Bani-Domi, Ibrahim Al-Adham, Mo'tasem M Alsmadi, Faten Awaysheh, Hisham Aqrabawi, Ahmad Al-Ghazawi, Ayman Rabayah
Saliva versus Plasma Therapeutic Drug Monitoring of Gentamicin in Jordanian Preterm Infants. Development of a Physiologically-Based Pharmacokinetic (PBPK) Model and Validation of Class II Drugs of Salivary Excretion Classification System. Drug research 70 (10) (2020)
Mo'tasem M Alsmadi, Mahdi Qasem Alfarah, Jawaher Albderat, Ghazi Alsalaita, Reham AlMardini, Salim Hamadi, Ahmad Al-Ghazawi, Omar Abu-Duhair, Nasir M Idkaidek
The development of a population physiologically based pharmacokinetic model for mycophenolic mofetil and mycophenolic acid in humans using data from plasma, saliva, and kidney tissue. Biopharmaceutics & drug disposition 40 (9) (2019)